Abstract:Worldwide, sepsis is a well-recognized cause of death. Acute kidney injury (AKI) may be related to sepsis in up to 70% of AKI cases. Sepsis-associated AKI (SA-AKI) is defined as the presence of AKI according to the Kidney Disease: Improving Global Outcomes criteria in the context of sepsis. SA-AKI is categorized into early, which presents during the first 48 h of sepsis, and late, presenting between 48 h and 7 days of sepsis. SA-AKI is associated with a worse prognosis among patients with sepsis. However, there are different SA-AKI phenotypes as well as different pathophysiological pathways of SA-AKI. The aim of this review is to provide an updated synopsis of the pathogenetic mechanisms underlying the development of SA-AKI as well as to analyze its different phenotypes and prognosis. In addition, potential novel diagnostic and prognostic biomarkers as well as therapeutic approaches are discussed. A plethora of mechanisms are implicated in the pathogenesis of SA-AKI, including inflammation and metabolic reprogramming during sepsis; various types of cell death such as apoptosis, necroptosis, pyroptosis and ferroptosis; autophagy and efferocytosis; and hemodynamic changes (macrovascular and microvascular dysfunction). Apart from urine output and serum creatinine levels, which have been incorporated in the definition of AKI, several serum and urinary diagnostic and prognostic biomarkers have also been developed, comprising, among others, interleukins 6, 8 and 18, osteoprotegerin, galectin-3, presepsin, cystatin C, NGAL, proenkephalin A, CCL-14, TIMP-2 and L-FABP as well as biomarkers stemming from multi-omics technologies and machine learning algorithms. Interestingly, the presence of long non-coding RNAs (lncRNAs) as well as microRNAs (miRNAs), such as PlncRNA-1, miR-22-3p, miR-526b, LncRNA NKILA, miR-140-5p and miR-214, which are implicated in the pathogenesis of SA-AKI, may also serve as potential therapeutic targets. The combination of omics technologies represents an innovative holistic approach toward providing a more integrated view of the molecular and physiological events underlying SA-AKI as well as for deciphering unique and specific phenotypes. Although more evidence is still necessary, it is expected that the incorporation of integrative omics may be useful not only for the early diagnosis and risk prognosis of SA-AKI, but also for the development of potential therapeutic targets that could revolutionize the management of SA-AKI in a personalized manner.

Epigenetic Mechanisms in Sepsis-Associated Acute Kidney Injury

Sepsis-Associated Acute Kidney Injury: Where Are We Now?

Gene Expression Profiling of Sepsis-Associated Acute Kidney Injury

Epigenetic dysregulation of autophagy in sepsis-induced acute kidney injury: the underlying mechanisms for renoprotection

The Role of Inflammatory Response and Metabolic Reprogramming in Sepsis-Associated Acute Kidney Injury: Mechanistic Insights and Therapeutic Potential

Acute Kidney Injury in Sepsis

Sepsis-Associated Acute Kidney Injury: What's New Regarding Its Diagnostics and Therapeutics?

Epigenetic regulation in the acute kidney injury to chronic kidney disease transition

Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup

Biomarkers, Diagnosis and Management of Sepsis-Induced Acute Kidney Injury: a Narrative Review.

Immunoregulatory mechanism of acute kidney injury in sepsis: A Narrative Review

Transcriptomic analysis and laboratory experiments reveal potential critical genes and regulatory mechanisms in sepsis-associated acute kidney injury

Sepsis-associated acute kidney injury - treatment standard.

Epigenetic Modification Drives Acute Kidney Injury-to-Chronic Kidney Disease Progression

Recent Advances in Sepsis-Induced Acute Kidney Injury

The aftermath of acute kidney injury: a narrative review of long-term mortality and renal function

Recent advances in the pharmacological management of sepsis-associated acute kidney injury

Epigenetics and Acute Kidney Injury

Metabolic reprogramming in septic acute kidney injury: pathogenesis and therapeutic implications

Non-Coding RNAs in Sepsis-Associated Acute Kidney Injury

Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials